Skip to main content

Journals in Life sciences

  • Molecular Aspects of Medicine

    • ISSN: 0098-2997
    Molecular Aspects of Medicine is a review journal for Physicians and Biomedical Scientists and an official journal of the International Union of Biochemistry and Molecular Biology. Molecular Aspects of Medicine aims to encourage the bridging of the gap between clinicians of all relevant specialities and biomedical scientists. The journal anticipates that most of the authors contributing to the series will be practising clinical scientists who will develop their own personal perspective as an extended review on the molecular aspects of a field of medicine in which they are working, addressing themselves both to the doctor who is ill-at-ease with basic science, and to the basic scientist with little awareness of the problems of clinical practice.It publishes articles on a spectrum of topics in medicine to illustrate not only the molecular insights that derive from the application of basic science, but also the variety of challenging problems that medicine is able to offer the basic scientist.Submission... on from biochemistry and molecular and cell biology to physiology, pharmacology and pathology are particularly welcomed.
  • Food and Chemical Toxicology

    • ISSN: 0278-6915
    Affiliated with the Chinese Society of ToxicologyFood and Chemical Toxicology (FCT) is an internationally renowned journal that publishes original research articles and reviews on toxic effects and toxic mechanisms of natural or synthetic chemicals occurring in the human environment (present in food and/or the human environment). The scope of the journal includes drugs, consumer chemicals/products (e.g. cosmetics); agricultural chemicals/products (e.g. pesticides) and industrial chemicals (e.g relevant to occupational exposure). Areas such as safety evaluation of novel foods and ingredients, biotechnologically-d... products and nanomaterials are included in the scope of the journal. In these cases, a comprehensive characterisation of the materials under evaluation is necessary. FCT also encourages submission of papers on inter-relationships between nutrition and toxicology and on in vitro techniques, particularly those fostering the 3 Rs.In addition, the journal also publishes Special Issues focussed on selected subject areas. These issues typically involve new areas of interest or concern and there will be some flexibility in the papers considered in terms of scope.The principal aim of the journal is to publish high impact, scholarly work and to serve as a multidisciplinary forum for research in Toxicology. Papers submitted will be judged on the basis of scientific originality and contribution to the field, quality and subject matter.Contributors who do not heed the requirements outlined in the instructions to authors and Editorials risk manuscript rejection without further consideration.Studie... should address at least one of the following:Adverse physiological/bioche... or pathological changes induced by specific defined substances,New techniques for assessing potential toxicity,Mechanisms underlying toxic phenomena,Toxicologi... examinations of specific chemicals or consumer products, both those showing adverse effects and those demonstrating safety, that meet current standards of scientific acceptability.Author... must clearly and briefly identify what novel toxic effect (s) or toxic mechanism (s) of the chemical are being reported and what their significance is in the abstract.Studies that consider time- and dose-response effects are likely to be considered more reliable and therefore considered more favourably.Manuscrip... describing research involving the following areas will not be considered:materials... of only local interest,materials/s... for which the chemical composition is not clearly defined,only pharmacological properties or potentially beneficial effects, chemical analyses of toxins in foods without addressing the toxic implication to humans [i.e. a risk assessment should be included],unrealisti... human doses, inappropriate route(s) of exposure, or in vitro experiments that do not reflect serum levels in humans without a compelling justification.FCT is committed to the highest standards. Only papers that have not been previously published, that fit in the above-mentioned scope, and which have been reviewed by experts in the field prior to publication will be considered for eventual publication. Cover letters must be included and state that the manuscript is new and original and not under consideration for publication elsewhere. Co-authors should be individuals who have contributed substantially to the content of the papers. All authors must declare any potential conflict of interest and all financial support.Any papers offered re-submission after review must contain a separate letter containing a response to all the points raised by the Editors and reviewers.
  • Developmental Biology

    • ISSN: 0012-1606
    The journal Developmental Biology (DB) publishes original research on mechanisms of development, differentiation, growth, homeostasis and regeneration in animals and plants at the molecular, cellular, genetic and evolutionary levels.Areas of particular emphasis include transcriptional control mechanisms, embryonic patterning, cell-cell interactions, growth factors and signal transduction, and regulatory hierarchies in developing plants and animals.Research Areas Include:Regulation of stem cells and regenerationGene regulatory networksMorphogenesi... and self organizationDifferen... in vivo and in vitro (organoids)Growth factors and oncogenesGenetics and epigenetics of developmentEvolution of developmental controlAnalysis of development at the single cell levelDB is affiliated with the Society for Developmental Biology.
  • Chemico-Biological Interactions

    • ISSN: 0009-2797
    A journal of molecular, cellular and biochemical toxicologyChemico-Bi... Interactions publishes research reports and review articles that examine the molecular, cellular, and/or biochemical basis of toxicologically relevant outcomes. Special emphasis is placed on toxicological mechanisms associated with interactions between chemicals and biological systems. Outcomes may include all traditional endpoints caused by synthetic or naturally occurring chemicals, both in vivo and in vitro. Endpoints of interest include, but are not limited to carcinogenesis, mutagenesis, respiratory toxicology, neurotoxicology, reproductive and developmental toxicology, and immunotoxicology.CBI discourages papers that are descriptive in nature and that do not address toxicological mechanisms (e.g., reports of toxicological effects following chemical exposure in absence of mechanistic experiments). CBI also discourages papers reporting on toxicological effects from materials, such as plant extracts or herbal medicines, that have not been chemically characterized.
  • Reproductive Toxicology

    • ISSN: 0890-6238
    Reproductive Toxicology is affiliated with the European Teratology SocietyDrawing from a large number of disciplines, Reproductive Toxicology publishes timely, original research on the influence of chemical and physical agents on reproduction. Written by and for obstetricians, pediatricians, embryologists, teratologists, geneticists, toxicologists, andrologists, and others interested in detecting potential reproductive hazards, the journal is a forum for communication among researchers and practitioners. Articles focus on the application of in vitro, animal and clinical research to the practice of clinical medicine.All aspects of reproduction are within the scope of Reproductive Toxicology, including the formation and maturation of male and female gametes, sexual function, the events surrounding the fusion of gametes and the development of the fertilized ovum, nourishment and transport of the conceptus within the genital tract, implantation, embryogenesis, intrauterine growth, placentation and placental function, parturition, lactation and neonatal survival.Adverse reproductive effects in males will be considered as significant as adverse effects occurring in females. To provide a balanced presentation of approaches, equal emphasis will be given to clinical and animal or in vitro work.Typical end points that will be studied by contributors include:InfertilityS... dysfunctionSpontaneo... abortionMalformation... histogenesisStillbir... growth retardationPrematuri... abnormalitiesPerinat... mortality
  • Neurotoxicology and Teratology

    • ISSN: 0892-0362
    Affiliated with the The Developmental Neurotoxicology Society, formerly known as The Neurobehavioral Teratology Society.Neurotoxicol... and Teratology provides a forum for publishing new information regarding the effects of chemical and physical agents on the developing, adult, or aging nervous system. In this context, the fields of neurotoxicology and teratology include studies of agent-induced alterations of nervous system function, with a focus on behavioral outcomes and their underlying physiological, neurochemical, molecular, and immunological mechanisms. The Journal publishes original, peer-reviewed Research Reports of experimental, clinical, and epidemiological studies that address the neurotoxicity and/or functional teratology of pesticides, solvents, heavy metals, nanomaterials, organometals, industrial compounds, mixtures, drugs of abuse, pharmaceuticals, animal and plant toxins, atmospheric reaction products, and physical agents such as radiation and noise. These reports include traditional mammalian neurotoxicology experiments, human studies, studies using non-mammalian animal models, and mechanistic studies in vivo or in vitro. Special Issues, Reviews, Commentaries, and Symposium Papers provide timely updates on areas that have reached a critical point of synthesis, on aspects of a scientific field undergoing rapid change, or on areas that present special methodological or interpretive problems. Theoretical Articles address concepts and potential mechanisms underlying interactions of agents of interest with the nervous system. Short Communications concisely describe a new method, technique, apparatus, or experimental result.
  • Current Opinion in Genetics & Development

    • ISSN: 0959-437X
    Current Opinion in Genetics and Development aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.In Current Opinion in Genetics and Development we help the reader by providing in a systematic manner:1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Current Opinion in Genetics and Development is part of the Current Opinion and Research (CO+RE) suite of journals . CO+RE journals leverage the Current Opinion legacy of editorial excellence, high-impact, and global reach to ensure they are a widely-read resource that is integral to scientists' workflows.Current Opinion in Genetics and Development will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.Division of the subject into sectionsThe subject of Genetics and Development is divided into six themed sections, each of which is reviewed once a year:• Cancer Genomics • Genome Architecture and Expression • Molecular and genetic basis of disease • Developmental mechanisms, patterning and evolution • Cell reprogramming, regeneration and repair • Genetics of Human Origin / Evolutionary genetics (alternate years)Selection of topics to be reviewedSection Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. The Editorial Board provides support to the Editors and the Section Editors with their comments and suggestions on names and topics.Review articles in Current Opinion in Genetics and Development are by invitation only.Review ArticlesThe Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. In the Current Opinion journals, we help the reader by providing in a systematic manner: (1) The views of experts on current advances in the field in a clear and readable form. (2) Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.The aim of the manuscript is to review recent articles, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, you are encouraged to give your subjective opinion of the topics discussed, although you should not concentrate unduly on your own research. Your review should be approximately 2000 words (not including references or reference notes), with approximately 50 references and, as such, the review is intended to be a concise view of the field as it is at the moment, rather than a comprehensive overview. Our audience ranges from student to professor, so articles must be accessible to a wide readership. Please avoid jargon, but do not oversimplify: be accurate and precise throughout. Occasionally, unpublished data can be referred to, but only when essential and should never be used to substantiate any significant point.Please see further information under Writing and Formatting – Additional information. Editorial OverviewSection Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.This successful format has made Current Opinion in Genetics and Development one of the most highly regarded and highly cited review journals in the field.
  • International Journal of Pharmaceutics

    • ISSN: 0378-5173
    The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.Editorial Policy The over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the consent of the Editors and Publisher.Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles.
  • Journal of Bioscience and Bioengineering

    • ISSN: 1389-1723
    The Journal of Bioscience and Bioengineering (JBB) is published by the Society for Biotechnology, Japan and distributed outside Japan by Elsevier.JBB aims to contribute to the advancement and dissemination of knowledge and technology in the fields of bioscience and biotechnology.It publishes papers on a broad range of topics in the areas of:Genetics, molecular biology, and gene engineeringEnzymolog... protein engineering, and enzyme technologyMicrobial physiology and biotechnologyBrewing and food technologyEnvironmen... biotechnologyBiochem... engineeringPlant biotechnologyCell and tissue engineeringBiomedica... engineeringBioinform... systems biology, and structural biology, which hold much promise for the future, are also within the scope of JBB.The journal only considers submissions that report on the most significant and fundamental advances in the field of bioscience and bioengineering. Manuscripts that describe optimizations related to phenomena of narrow interest using conventional statistical approaches and/or describe exclusively computer simulation with conventional enzyme reaction models or molecular dynamics, will be rejected without peer review.The brewing and food technology section welcomes research that provide fundamental advances on fermentation, fermented foods and their process developments. Basic studies solely treating the chemical and/or medicinal aspects of food derivatives prepared by conventional pretreatment techniques are not appropriate for JBB.The cell and tissue engineering section covers research on cell culture engineering as it relates to regenerative medicine. Topics include the technologies for stem cell culture such as mass production, differentiation control, and tissue reconstruction. Studies in the field of pure cell biology and embryology are not appropriate for JBB.The biomedical engineering section covers topics related to bioprocess engineering in the field of medicine, including biomaterials, scaffolds, artificial organs, drug delivery systems, microfluidics, and micro-fabrication, but not deals with the topics mainly focusing on mechanical engineering. Studies in the field of basic medicine, pharmaceutical sciences, dentistry, and surgical technique are not suitable for JBB. The journal does not consider pathological, clinical, and epidemiological research.
  • Current Opinion in Toxicology

    • ISSN: 2468-2020
    Affiliated with the International Union of ToxicologyCurrent Opinion in Toxicology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise, and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.In Current Opinion in Toxicology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Current Opinion in Toxicology serves as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.Current Opinion in Toxicology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Toxicology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.Division of the subject into sections: For this purpose, the scope of Current Opinion in Toxicology is divided into seven selected, high impact themed sections:Mechanistic ToxicologyMetabolic ToxicologyRisk assessment in ToxicologyGenomic ToxicologySystems ToxicologyTranslatio... ToxicologyGeneral Toxicology (direct submission)Expertise... Expert authors, who are leaders in their field, are invited to write short review articles in which they present recent developments in their subject and provide short annotations to the papers that they think are most relevant. Comprehensiveness: There are 27 high-impact Current Opinion review journals in a range of subjects from food science to green and sustainable chemistry. Impact: In addition to a vast readership, Current Opinion titles enjoy high citations, Impact Factors, and CiteScores. Discoverability: Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast, global audience.Selection of topics to be reviewed Editors, who are major authorities in the field, are approved by the Editors-in-Chief of the journal. They divide their sections into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Editors commission reviews from authors on each topic that they have selected and arrange for the peer review process. The papers are reviewed by 2 independent reviewers.Submission... Opinion in Toxicology allows two ways to submit to the journal:Invitation – in accordance with the established procedure for all Current Opinion titles, andDirect submission - authors are invited to submit directly via the submission system Editorial Manager. All submissions are subject to the standard, rigorous peer review by the journal Editors, as well as completeness and relevance check at submission to ensure high quality and research integrity requirements are met. The direct submission papers, if accepted, will be published in the General Toxicology section of the journal.Short ReviewsAuthors are asked to submit short review opinion type articles, in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the 5 years. Original research papers and systematic reviews will not be considered. These can be submitted to the companion journal Current Research in Toxicology.Editorial Overview For invitation only sections, Section Editors write a short overview at the beginning of the section, to introduce the reviews and to draw the reader's attention to any particularly interesting developments.Ethics in Publishing: General Statement The Editors and the Publisher of this journal believe that there are fundamental principles underlying scholarly and professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper, are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the journal is the safest course. All submissions to the journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The journal may use such information as a basis for editorial decisions and may publish such disclosures, if they are believed to be important to readers in judging the manuscript. A decision may be made by the journal not to publish on the basis of the declared conflict.For more information, please refer to: https://www.elsevier...